Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vesper Bio is a clinical-stage biotech company that employs a sortilin inhibitor to rebalance progranulin levels in patients. In conditions where the sortilin receptor would otherwise reduce circulating and extracellular progranulin, Vesper Bio aims to address the underlying disease mechanisms. The company is at the forefront of sortilin biology, boasting a robust background in biopharma. Supported by an outstanding multinatio...
Vesper Bio is a clinical-stage biotech company that employs a sortilin inhibitor to rebalance progranulin levels in patients. In conditions where the sortilin receptor would otherwise reduce circulating and extracellular progranulin, Vesper Bio aims to address the underlying disease mechanisms. The company is at the forefront of sortilin biology, boasting a robust background in biopharma. Supported by an outstanding multinational scientific advisory board, which includes prominent key opinion leaders, Vesper Bio is pioneering advancements in this field.

List your booth number for exhibitions, ask us